Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 3
24
Views
0
CrossRef citations to date
0
Altmetric
Original Research: Surgery and COVID-19

Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients

, MD, , MD, , MDORCID Icon, , DO, , MD, , DO, , MD, , MD, , MD, , MD & , MD show all
Pages 414-423 | Received 05 Nov 2023, Accepted 14 Feb 2024, Published online: 19 Mar 2024

  • Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clin Investig Arterioscler. 2021;33(3):151–157. doi:10.1016/J.ARTERI.2020.10.001.
  • Xu J, Murphy SL, Kochanek KD, Arias E. Mortality in the United States, 2021. NCHS Data Brief. 2022;(456):1–8. doi:10.15620/CDC:112079.
  • Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J. 2020;56(2):2002108. doi:10.1183/13993003.02108-2020.
  • Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/JOURNAL.PONE.0233147.
  • Linares L, Cofan F, Diekmann F, et al. A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients. PLoS One. 2021;16(3):e0247251. doi:10.1371/JOURNAL.PONE.0247251.
  • Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20(7):1800–1808. doi:10.1111/AJT.15941.
  • Pereira MR, Arcasoy S, Farr MA, et al. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. Transpl Infect Dis. 2021;23(4):e13637. doi:10.1111/TID.13637.
  • NIS Database Documentation. Accessed August 10, 2022. https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
  • HCUP-US NIS Overview. Accessed January 2, 2023. https://www.hcup-us.ahrq.gov/nisoverview.jsp#about.
  • UNOS. OPTN Policy Changes and Organ Allocation Guidelines. Accessed March 10, 2023. https://unos.org/policy/.
  • Katabathina V, Menias CO, Pickhardt P, Lubner M, Prasad SR. Complications of immunosuppressive therapy in solid organ transplantation. Radiol Clin North Am. 2016;54(2):303–319. doi:10.1016/J.RCL.2015.09.009.
  • Sheikh SS, Locke JE. Gender disparities in transplantation. Curr Opin Organ Transplant. 2021;26(5):513–520. doi:10.1097/MOT.0000000000000909.
  • OPTN. National data. Accessed March 10, 2023. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#.
  • Rinaldi M, Bartoletti M, Bussini L, et al. COVID-19 in solid organ transplant recipients: No difference in survival compared to general population. Transpl Infect Dis. 2021;23(1):e13421. doi:10.1111/TID.13421.
  • Avery RK, Chiang TPY, Marr KA, et al. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. Am J Transplant. 2021;21(7):2498–2508. doi:10.1111/AJT.16431.
  • Hadi YB, Naqvi SFZ, Kupec JT, Sofka S, Sarwari A. Outcomes of COVID-19 in solid organ transplant recipients: A propensity-matched analysis of a large research network. Transplantation. 2021;105(6):1365–1371. doi:10.1097/TP.0000000000003670.
  • Caillard S, Chavarot N, Francois H, et al. Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021;21(3):1295–1303. doi:10.1111/AJT.16424.
  • Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL. Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. Obesity (Silver Spring). 2020;28(9):1595–1599. doi:10.1002/OBY.22913.
  • Choi MH, Kim D, Choi EJ, et al. Mortality prediction of patients in intensive care units using machine learning algorithms based on electronic health records. Sci Rep. 2022;12(1):7180. doi:10.1038/S41598-022-11226-4.
  • Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26(1):30–39. doi:10.1038/S41380-020-00880-7.
  • Marik PE, Deperrior SE, Ahmad Q, Dodani S. Gender‐based disparities in COVID-19 patient outcomes. J Investig Med. 2021;69(4):814–818. doi:10.1136/JIM-2020-001641.
  • Chaudhry ZS, Williams JD, Vahia A, et al. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study. Am J Transplant. 2020;20(11):3051–3060. doi:10.1111/AJT.16188.
  • Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–164. doi:10.3947/IC.2020.52.2.154.
  • Alfishawy M, Elbendary A, Mohamed M, Nassar M. COVID-19 mortality in transplant recipients. Int J Organ Transplant Med. 2020;11(4):145–162. 2023.
  • Kates OS, Haydel BM, Florman SS, et al. Coronavirus disease 2019 in solid organ transplant: A multicenter cohort study. Clin Infect Dis. 2021;73(11):E4090–E4099. doi:10.1093/CID/CIAA1097.
  • Evran T, Serin S, Gürses E, Sungurtekin H. Various scoring systems for predicting mortality in intensive care unit. Niger J Clin Pract. 2016;19(4):530–534. doi:10.4103/1119-3077.183307.
  • OPTN. All-time records again set in 2021 for organ transplants, organ donation from deceased donors. Accessed January 16, 2023. https://optn.transplant.hrsa.gov/news/all-time-records-again-set-in-2021-for-organ-transplants-organ-donation-from-deceased-donors/.
  • Lsrani AK. OPTN/SRTR 2020 annual data report: Introduction. Am J Transplantation. 2022;22(S2):11–20. doi:10.1111/AJT.16974.
  • Palmisano A, Gandolfini I, Delsante M, et al. Acute kidney injury (AKI) before and after kidney transplantation: Causes, medical approach, and implications for the long-term outcomes. J Clin Med. 2021;10(7):1484. doi:10.3390/JCM10071484.
  • Ehrsam J, Rössler F, Horisberger K, Hübel K, Nilsson J, de Rougemont O. Kidney retransplantation after graft failure: Variables influencing long-term survival. J Transplant. 2022;2022:3397751–3397758. doi:10.1155/2022/3397751.
  • Mohammed AH, Blebil A, Dujaili J, Rasool-Hassan BA. The risk and impact of COVID-19 pandemic on immunosuppressed patients: Cancer, HIV, and solid organ transplant recipients. AIDS Rev. 2020;22(3):151–157. doi:10.24875/AIDSREV.20000052.
  • Demir E, Ucar ZA, Dheir H, et al. COVID-19 in kidney transplant recipients: A multicenter experience from the first two waves of pandemic. BMC Nephrol. 2022;23(1):183. doi:10.1186/S12882-022-02784-W/TABLES/5.
  • Faour WH, Choaib A, Issa E, et al. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflamm Res. 2022;71(1):39–56. doi:10.1007/S00011-021-01520-8.
  • Kronbichler A, Gauckler P, Windpessl M, et al. COVID-19: implications for immunosuppression in kidney disease and transplantation. Nat Rev Nephrol. 2020;16(7):365–367. doi:10.1038/s41581-020-0305-6.
  • Jing L, Chen W, Guo L, et al. Acute kidney injury after lung transplantation: a narrative review. Ann Transl Med. 2021;9(8):717–717. doi:10.21037/ATM-20-7644.
  • Scudiero F, Silverio A, di Maio M, et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res. 2021;198:34–39. doi:10.1016/J.THROMRES.2020.11.017.
  • Suh YJ, Hong H, Ohana M, et al. Pulmonary embolism and deep vein thrombosis in COVID-19: A systematic review and meta-analysis. Radiology. 2021;298(2):E70–E80. doi:10.1148/RADIOL.2020203557.
  • Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440. doi:10.1016/S2352-3026(20)30145-9.
  • Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142(17):1609–1611. doi:10.1161/CIRCULATIONAHA.120.050354.
  • Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. doi:10.1016/S2352-3026(20)30216-7.
  • Knight R, Walker V, Ip S, et al. Association of COVID-19 with major arterial and venous thrombotic diseases: A population-wide cohort study of 48 million adults in England and Wales. Circulation. 2022;146(12):892–906. doi:10.1161/CIRCULATIONAHA.122.060785.
  • Cesar A, Keller M. Solid organ transplantation overview and selection criteria. 2015. Accessed January 25, 2023. https://www.ajmc.com/view/ace022_jan15_keller.
  • de Pietri L, Montalti R, Nicolini D, Troisi RI, Moccheggiani F, Vivarelli M. Perioperative thromboprophylaxis in liver transplant patients. World J Gastroenterol. 2018;24(27):2931–2948. doi:10.3748/WJG.V24.I27.2931.
  • Lichvar AB, Pierce DR, Salerno D, Klem P, Waldman G, Park JM. Utilization of direct-acting oral anticoagulation in solid organ transplant patients: A national survey of institutional practices. Clin Transplant. 2020;34(6):e13853. doi:10.1111/CTR.13853.
  • ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385(9):790–802. doi:10.1056/NEJMoa2105911.
  • Upadhya S, Rehman J, Malik AB, Chen S. Mechanisms of lung injury induced by SARS-CoV-2 infection. Physiology (Bethesda). 2022;37(2):88–100. doi:10.1152/PHYSIOL.00033.2021.
  • Camporota L, Cronin JN, Busana M, Gattinoni L, Formenti F. Pathophysiology of coronavirus-19 disease acute lung injury. Curr Opin Crit Care. 2022;28(1):9–16. doi:10.1097/MCC.0000000000000911.
  • Rilinger J, Zotzmann V, Bemtgen X, et al. Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno-venous extracorporeal membrane oxygenation therapy. Artif Organs. 2021;45(9):1050–1060. doi:10.1111/AOR.13954.
  • Monreal E, Maza SSdl, Gullón P, et al. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study. J Med Virol. 2021;93(4):2243–2251. doi:10.1002/JMV.26656.
  • Brown MJ, Alazawi W, Kanoni S. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021;385(12):1147. doi:10.1056/NEJMc2108482.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.